449 related articles for article (PubMed ID: 22475140)
1. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
[TBL] [Abstract][Full Text] [Related]
2. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
4. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
[TBL] [Abstract][Full Text] [Related]
5. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
6. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
7. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
8. [Predictive value of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women with high viremia].
Sun W; Ma L; Hao A; Liu W; Song M; Li M; Xin Y
Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):180-3. PubMed ID: 25938829
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
Han GR; Jiang HX; Wang CM; Ding Y; Wang GJ; Yue X; Zhou L; Zhao W
J Viral Hepat; 2017 Jun; 24(6):514-521. PubMed ID: 28039902
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
11. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
[TBL] [Abstract][Full Text] [Related]
12. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study.
Hu Y; Xu C; Xu B; Hu L; Liu Q; Chen J; Liu J; Liu L; Yang J; Chen T; Wen J; Jiang N; Zhang Y; Cao M; Feng J; Lin X; Wang Z; Xu B; Zhou YH
J Viral Hepat; 2018 Apr; 25(4):429-437. PubMed ID: 29193547
[TBL] [Abstract][Full Text] [Related]
14. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
15. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
16. [The safety of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women after discontinuation].
Deng Y; Wu W; Zhang D; Hu P; Kang J; Yang Y; Zeng W
Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):586-9. PubMed ID: 26447621
[TBL] [Abstract][Full Text] [Related]
17. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Xu J; Tao LL; Ma LX
J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Jiang HX; Yue X; Ding Y; Wang CM; Wang GJ; Yang YF
J Viral Hepat; 2015 Sep; 22(9):754-62. PubMed ID: 25641421
[TBL] [Abstract][Full Text] [Related]
20. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
